vaccines

Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
Fierce Pharma
Merck
GSK
vaccines
drug shortages
hepatitis A
Vaqta
Havrix
Flag link:
Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up
Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up
Reuters
Dynavax
hepatitis B
vaccines
FDA
HEPLISAV-B
Flag link:
Seqirus investing $52M, adding 100 jobs to U.K. flu vaccine site prompted by thoughts of pandemics
Seqirus investing $52M, adding 100 jobs to U.K. flu vaccine site prompted by thoughts of pandemics
Fierce Pharma
Seqirus
UK
flu vaccines
vaccines
drug manufacturing
Flag link:
Industry's favored flu shot production process hurt efficacy last year: study
Industry's favored flu shot production process hurt efficacy last year: study
Fierce Pharma
drug manufacturing
vaccines
flu vaccines
Flag link:
Watch out Sanofi: Takeda’s new data on dengue vaccine is good news for PhIII trial
Watch out Sanofi: Takeda’s new data on dengue vaccine is good news for PhIII trial
Endpoints
Sanofi
Takeda
vaccines
dengue
TAK-003
Flag link:
Sanofi inks AI pact to learn more about flu vaccine responses
Sanofi inks AI pact to learn more about flu vaccine responses
Fierce Pharma
Sanofi
artificial intelligence
vaccines
flu vaccines
Flag link:
Vaccine approval buoys GSK new drug push
Vaccine approval buoys GSK new drug push
Biopharma Dive
GSK
Shingrix
shingles
vaccines
Merck
Zostavax
Flag link:
A new peanut allergy vaccine failed in a trial, but the company wants it approved anyway
A new peanut allergy vaccine failed in a trial, but the company wants it approved anyway
Stat
vaccines
food allergies
peanut allergy
DBV Technologies
Viaskin Peanut
Flag link:
GlaxoSmithKline wins blockbuster green light with Shingrix, its new shingles vaccine
GlaxoSmithKline wins blockbuster green light with Shingrix, its new shingles vaccine
Fierce Pharma
GSK
vaccines
shingles
FDA
Shingrix
Flag link:
Pneumonia vaccine triples protection in animal models
Pneumonia vaccine triples protection in animal models
Fierce Biotech
vaccines
pneumonia
antibiotic resistance
Merck
Pneumovax 23
Pfizer
Prevnar 13
Flag link:
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix
Fierce Pharma
GSK
vaccines
Shingrix
shingles
Flag link:
Sanofi commits €170M to expand flu vaccines production
Sanofi commits €170M to expand flu vaccines production
Biopharma Dive
Sanofi
vaccines
flu vaccines
Flag link:
Merck's Gardasil 9 offers at least 6 years of cancer protection, data show
Merck's Gardasil 9 offers at least 6 years of cancer protection, data show
Fierce Pharma
Merck
Gardasil 9
vaccines
HPV
cervical cancer
Flag link:
Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit
Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit
Yahoo/Zacks.com
Emergent BioSolutions
Sanofi
M&A
smallpox
vaccines
ACAM2000
Flag link:
Zika virus: positive results for Inovio’s vaccine published in NEJM
Zika virus: positive results for Inovio’s vaccine published in NEJM
GoinPharma
Zika virus
Zika vaccine
vaccines
Inovio
GLS-5700
Flag link:
Inovio touts first-in-man Ph1 trial of Zika virus vaccine
Inovio touts first-in-man Ph1 trial of Zika virus vaccine
Drug Delivery Business News
Inovio
vaccines
clinical trials
Zika virus
Zika vaccine
GLS-5700
Flag link:
Promising Ebola vaccines from Merck, Johnson & Johnson win BARDA funding
Promising Ebola vaccines from Merck, Johnson & Johnson win BARDA funding
Fierce Pharma
ebola virus
vaccines
Merck
JNJ
BARDA
Flag link:
With an FDA decision looming, Dynavax is shopping a deal on Heplisav — report
With an FDA decision looming, Dynavax is shopping a deal on Heplisav — report
Endpoints
FDA
Dynavax Technologies
Heplisav
vaccines
hepatitis B
Flag link:
Sinovac’s chickenpox vaccine shows 87% efficacy in topline phase 3
Sinovac’s chickenpox vaccine shows 87% efficacy in topline phase 3
Fierce Pharma
Sinovac
vaccines
chicken pox
varicella zoster
Flag link:
J&J, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D
J&J, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D
Fierce Pharma
JNJ
BARDA
pandemic flu
vaccines
R&D
Flag link:

Pages